FDA grants South Texas Blood & Tissue Center first license for new process that triples shelf life of critically needed platelets
28. Februar 2020 08:45 ET
|
BioBridge Global
San Antonio, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has granted the South Texas Blood & Tissue Center (STBTC) a license to use a new process shown to...